Abstract
Six hundred and eighty-four primary breast cancers from the International (Ludwig) Breast Cancer Study Group (IBCSG) were studied for Helix pomatia lectin (HPA) binding. There was a weak correlation between lymph node-positive and HPA positive (P = 0.04). In our series there was a large advantage in disease-free survival (DFS) and overall survival (OS) for node-negative patients (P < 0.0001 DFS and OS). However, there was no such advantage for HPA-negative patients (P = 0.23 DFS and P = 0.32 OS). We conclude that in this randomised patient group HPA is of no clinical predictive value.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alam S. M., Whitford P., Cushley W., George W. D., Campbell A. M. Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer. Br J Cancer. 1990 Aug;62(2):238–242. doi: 10.1038/bjc.1990.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brooks S. A., Leathem A. J. Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Lancet. 1991 Jul 13;338(8759):71–74. doi: 10.1016/0140-6736(91)90071-v. [DOI] [PubMed] [Google Scholar]
- Fenlon S., Ellis I. O., Bell J., Todd J. H., Elston C. W., Blamey R. W. Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol. 1987 Jul;152(3):169–176. doi: 10.1002/path.1711520305. [DOI] [PubMed] [Google Scholar]
- Fukutomi T., Itabashi M., Tsugane S., Yamamoto H., Nanasawa T., Hirota T. Prognostic contributions of Helix pomatia and carcinoembryonic antigen staining using histochemical techniques in breast carcinomas. Jpn J Clin Oncol. 1989 Jun;19(2):127–134. [PubMed] [Google Scholar]
- Grundbacher F. J. Helix pomatia lectin-binding and predictive value in breast-cancer. Lancet. 1987 Nov 14;2(8568):1145–1145. doi: 10.1016/s0140-6736(87)91566-2. [DOI] [PubMed] [Google Scholar]
- Leathem A. J., Brooks S. A. Predictive value of lectin binding on breast-cancer recurrence and survival. Lancet. 1987 May 9;1(8541):1054–1056. doi: 10.1016/s0140-6736(87)90482-x. [DOI] [PubMed] [Google Scholar]
- Leathem A., Dokal I., Atkins N. Lectin binding to normal and malignant breast tissue. Diagn Histopathol. 1983 Jul-Dec;6(3-4):171–180. [PubMed] [Google Scholar]
- Prediction of lymph node involvement in breast cancer. Lancet. 1991 Aug 10;338(8763):392–393. [PubMed] [Google Scholar]
- Taylor C. W., Anbazhagan R., Jayatilake H., Adams A., Gusterson B. A., Price K., Gelber R. D., Goldhirsch A. Helix pomatia in breast cancer. Lancet. 1991 Aug 31;338(8766):580–581. doi: 10.1016/0140-6736(91)91154-m. [DOI] [PubMed] [Google Scholar]
- Taylor C. W., Anbazhagan R., Jayatilake H., Adams A., Gusterson B. A., Price K., Gelber R. D., Goldhirsch A. Helix pomatia in breast cancer. Lancet. 1991 Aug 31;338(8766):580–581. doi: 10.1016/0140-6736(91)91154-m. [DOI] [PubMed] [Google Scholar]